369 related articles for article (PubMed ID: 32165212)
1. Insulin mediated novel therapies for the treatment of Alzheimer's disease.
Dubey SK; Lakshmi KK; Krishna KV; Agrawal M; Singhvi G; Saha RN; Saraf S; Saraf S; Shukla R; Alexander A
Life Sci; 2020 May; 249():117540. PubMed ID: 32165212
[TBL] [Abstract][Full Text] [Related]
2. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
4. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
5. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
6. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease.
Akhtar A; Sah SP
Neurochem Int; 2020 May; 135():104707. PubMed ID: 32092326
[TBL] [Abstract][Full Text] [Related]
7. The rise and fall of insulin signaling in Alzheimer's disease.
Chami B; Steel AJ; De La Monte SM; Sutherland GT
Metab Brain Dis; 2016 Jun; 31(3):497-515. PubMed ID: 26883429
[TBL] [Abstract][Full Text] [Related]
8. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
Kroner Z
Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
10. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
11. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
Hölscher C
Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
[TBL] [Abstract][Full Text] [Related]
12. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
13. Linking insulin with Alzheimer's disease: emergence as type III diabetes.
Ahmed S; Mahmood Z; Zahid S
Neurol Sci; 2015 Oct; 36(10):1763-9. PubMed ID: 26248483
[TBL] [Abstract][Full Text] [Related]
14. Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer's disease neuropathology.
Yang JJ
Acta Neurol Belg; 2022 Oct; 122(5):1135-1142. PubMed ID: 35482277
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
[TBL] [Abstract][Full Text] [Related]
16. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
Kang S; Lee YH; Lee JE
Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
18. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
de la Monte SM
Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
[TBL] [Abstract][Full Text] [Related]
19. Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.
Chen Y; Zhang J; Zhang B; Gong CX
Curr Top Med Chem; 2016; 16(5):485-92. PubMed ID: 26268336
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
Zhao WQ; Townsend M
Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
